Oncology

Novartis HQ in Basel, Switzerland (source Novartis)

Novartis to pay $3.9 bn for radiopharma drug & biz

By Flora Southey

Novartis has announced plans to buy radiopharmaceutical firm Advanced Accelerator Applications (AAA), which will add neuroendocrine tumour treatment Lutathera to its portfolio.